Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment by N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, F. N. Muradova, L. Y. Koroleva

“…Description of risk factors, pathogenesis and treatment strategies of gastrointestinal bleeding (GIB) in the course of antithrombotic therapy in patients with coronary heart disease (CHD).Key points. …”
Get full text

Bilateral Atypical Femoral Fractures in a Patient with Multiple Myeloma Treated with Intravenous Bisphosphonate Therapy by Ichiro Tonogai, Tomohiro Goto, Daisuke Hamada, Toshiyuki Iwame, Shinji Yoshioka, Takahiko Tsutsui, Yuichiro Goda, Hiroshi Egawa, Koichi Sairyo

“…Here we present a patient with bilateral atypical femoral fractures and multiple myeloma treated with intravenous bisphosphonate therapy.…”
Get full text

Applying a sustainability perspective in the literature on physical therapy in relation to pharmaceuticals: a scoping review by Patric Svensson, Magdalena Jacobsson, Annie Palstam, Annie Palstam, Annie Palstam, Elvira Lange, Elvira Lange

Subjects: “…physical therapy…”
Get full text

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review by Yan Chen, Yan Chen, Jiaojiao Zhao, Jiaojiao Zhao, Yifei Wang, Yifei Wang, Long Ge, Long Ge, Joey Sum-wing Kwong, Junjie Lan, Rui Zhang, Huaye Zhao, Linfang Hu, Jiaxue Wang, Shuimei Sun, Songsong Tan, Xiaoqing Lin, Rui He, Wenyi Zheng, Xiaosi Li, Jiaxing Zhang

“…ISA (SUCRA = 93.50%; mean rank, 1.20) seemed to be the most effective therapy in the above population. As to proven, probable, and possible IA patients, the triazoles were superior to D-AmB in terms of reducing all-cause mortality. …”
Get full text

Effect of Monotherapy and Combination Therapy of Pantoprazole and Aprepitant in Gastric Esophageal Reflux Disease in Albino Rats by Kamleshwar Shukla, Prince Raj, Arun Kumar, Mukesh Kumar, Gaurav Kaithwas

Get full text

Periodontal Therapy as an Adjunct to Pulmonary Rehabilitation in Chronic Respiratory Diseases: A Randomized Controlled Trial by Anuj S. Parihar, Neha Khare, Sneha Bayyapu, Maninderjit Kaur, Deepak Kochar, Rashmi Laddha

Subjects: Get full text

BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy by Vinay K. Pattalachinti, Emaan Haque, Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, Michael Overman, Christine M. Parseghian, Van K. Morris, Bryan Kee, Ryan W. Huey, Kanwal Raghav, Colin M. Court, John Paul Shen

“…Abstract Appendiceal Adenocarcinoma (AA) is a rare gastrointestinal cancer with no FDA-approved targeted therapies. Here, we retrospectively compare BRAF-mutant AA and colorectal cancer (CRC). …”
Get full text

Local controllability and optimal control for\newline a model of combined anticancer therapy with control delays by Jerzy Klamka, Helmut Maurer, Andrzej Swierniak

Subjects: “…combined cancer therapy…”
Get full text

The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy by Ryosuke Takegawa, Kei Hayashida, Atsushi Murao, Yusuke Endo, Cyrus E. Kuschner, Jacob Kazmi, Eriko Nakamura, Ping Wang, Lance B. Becker

“…Further refinement of these techniques is necessary for their clinical application in MTx therapy.…”
Get full text

Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review by Robert Root-Bernstein

“…Among those infected, the rate of progression to full-blown acquired immunodeficiency syndrome (AIDS) and susceptibility to various opportunistic infections varies widely as does their response to antiretroviral therapies (ARTs). This review addresses these conundrums in light of Pasteur’s principle that “the terrain is as important as the germ”. …”
Get full text

Group Psychological Therapy Program in Adult Patients with Congenital Heart Disease and Anxious–Depressive Symptoms by Efrén Martínez-Quintana, Karen Codana-Alcántara, Hector M. Montesdeoca-Naranjo, Marta Isabel García-Suárez, María Pino Fleitas-Álvarez, María Alcántara-Castellano, Alejandro Ruiz-Castellano, Ana González-Isasi, Fayna Rodríguez-González, Esperanza Bosch-Casañas

“…<i>Conclusions</i>: Group psychological therapy proved to be a useful tool to reduce depressive symptomatology after a 6-week program, providing a comfortable environment to patients with CHD.…”
Get full text

Rescue Therapy Using a Rifabutin-Based Regimen is Effective for Cure of Helicobacter pylori Infection by Sander Veldhuyzen van Zanten, Snehal Desai, Linda Best, Geraldine Cooper-Lesins, Dickran Malatjalian, David Haldane, Kevork Peltekian

“…OBJECTIVE: To evaluate the efficacy of rescue therapy using rifabutin, amoxicillin and a proton pump inhibitor (PPI) in the eradication of Helicobacter pylori in patients who have failed at least one course of PPI-based triple therapy.…”
Get full text

Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies by Apolline Lefèvre, Apolline Lefèvre, Zinnia P. Parra-Guillen, Zinnia P. Parra-Guillen, Iñaki F. Trocóniz, Iñaki F. Trocóniz, Iñaki F. Trocóniz, Christophe Boetsch, Nicolas Frances

“…Therefore, innovative dosing strategies need to be implemented to mitigate the risk of developing CRS.MethodIn the presented work, a mechanistic pharmacokinetics/pharmacodynamics (PKPD) model describing cytokine release following TCE therapy has been developed combining literature knowledge and preclinical data. …”
Get full text

Contraceptives or Hormone Replacement Therapy and Associations with Autoimmune Conditions: Exploring Effects of Estrogen Analog Supplementation by Irakli Tskhakaia, Yurilu Gonzalez Moret, Anna‐Kay Palmer, Diego Lema, M. Carolina Musri, Nanuka Tsibadze, Arthur Lau

“…The group who received combination therapy appeared to have lower risks of developing antiphospholipid syndrome (RR 0.7). …”
Get full text

Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy by Hironori Ochi, Masayuki Kurosaki, Takaaki Tanaka, Nobuharu Tamaki, Kaoru Tsuchiya, Yutaka Yasui, Hiroyuki Marusawa, Toshifumi Tada, Shinichiro Nakamura, Takehiro Akahane, Eisuke Okamoto, Haruhiko Kobashi, Hirotaka Arai, Michiko Nonogi, Namiki Izumi

“…Conclusions Severe proteinuria before lenvatinib as a second‐line therapy after atezolizumab‐bevacizumab treatment may affect the duration of lenvatinib administration and treatment efficacy.…”
Get full text

Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes by Juan P. Cata, Claudius Conrad, Katy Rezvani

“…We believe that the use of NK cell transfer therapy in the context of postoperative minimal residual disease deserves significant investigation.…”
Get full text

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia by Carlos Jiménez-Vicente, Iago Arribas, Helena Pomares, Guillermo Ramil, Sandra Castaño-Diez, Amanda Isabel Pérez-Valencia, Antonella Luciana Sturla, Mònica López-Guerra, Alexandra Martinez-Roca, Inés Zugasti, Francesca Guijarro, Albert Cortés-Bullich, Beatriz Merchán, Ana Triguero, Inés Monge, Albert Tuca, Guadalupe Oñate, Ana Garrido, Jorge Sierra, Montserrat Arnan, Jordi Esteve, Marina Díaz-Beyá, Spanish CETLAM Group

Get full text

The transformation of the image of God during the development of eating disorders and eventual therapy: a sociological study by Dariusz Tułowiecki

“… The text aims to present the image of God – a Higher Power being discovered as part of eating disorder therapy and the changes in the informant within her life. …”
Get full text

IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface by A.V. Antonova, V.P. Nikolaenko, V.V. Brzheskiy

“…<p> <b>IOP-lowering therapy and ocular surface in glaucoma. <br> Part 2. …”
Get full text

The role of HSPA14 in breast cancer: implications for tumorigenesis, immune response modulation, and personalized therapies by Ruipeng Zhao, Xiaocun Zhu, Wan Wei, Linlin Zhen

“…The expression of HSPA14 may also indicate drug sensitivity.Conclusion Our study elucidates the involvement of HSPA14 in tumorigenesis, particularly in modulating the immune response, shaping the immune microenvironment, and contributing to drug resistance, which are pivotal for the development of personalized breast cancer therapies.…”
Get full text